Ambri Limited is pioneering the integration of Biotechnology, Nanotechnology and Electronics with a major focus in the human medical diagnostics market.
The Company is Australian owned and was listed on the Australian Stock Exchange (ASX:ABI) in August 2001 and is currently located in Chatswood, Sydney, Australia.
Ambri has developed the Ion Channel Switch (ICS ™) Technology which is a patented, self assembling synthetic bio-membrane. This is one of the world's first true 'bio nano' devices and has a wide and varied potential of applications in which benefit from rapid, quantitative biosensing.
Ambri has retained exclusive commercialisation rights to professional human medical diagnostic applications, while it has licensed out other biosensor applications to its alliance partner Biosensor Enterprises LLC (BEL) – a joint venture company of Dow Corning Corporation and Genencor International Inc.)
| Contact Details: |
| 126 Greville Street |
| Chatswood |
| New South Wales |
| 2067 |
| Australia |
| Tel: | 61 2 9422 3000 |
| Fax: | 61 2 9422 3013 |
| Email: | Communications@ambri.com |
| WWW: | www.ambri.com/

|
| |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 262 times since April 2007, the link to the organisation's website has been followed 69 times
Search for more companies in Chatswood
Search for more companies in New South Wales
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
AMBRI